Home 2023

Archives

Scientific analysis of Alzheimer's disease in hospital, conceptual image

Lecanemab and other treatments: Glimmers of hope for alzheimer’s patients

Effective treatments for amyloid-associated neurological diseases are desperately needed; H. Robert Guy, CEO of Amyloid Research Consultants, talks us through the obstacles and opportunities associated with structure-based drug design.
MRI scan of brain

Understanding amyloid beta and Alzheimer’s disease: the key to helping AD patients

Efforts to prevent or treat Alzheimer’s Disease (AD) by targeting Amyloid beta (Aβ) assemblies should be continued, but the strategies should be altered dramatically.
MRI Brain Scan of head and skull with hand pointing

Understanding amyloid beta and Alzheimer’s disease: the key to helping AD patients

Efforts to prevent or treat Alzheimer’s Disease (AD) by targeting Amyloid beta (Aβ) assemblies should be continued, but the strategies should be altered dramatically.
Root causes of amyloid-associated diseases

Why are the root causes of amyloid-associated diseases so misunderstood and treatments so inadequate?

The annual worldwide cost of treating amyloid-associated diseases is about a trillion dollars and increasing steadily. But the human toll is worse Amyloids are killing...
amyloid, membrane channels structures

Amyloid oligomer & membrane channel structures

H. Robert Guy, CEO from Amyloid Research Consultants, ascertains why amyloid oligomer & membrane channels structures can & must be determined.

Follow Us

Advertisements